Replies to post #799310 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

If the stock hits 29 cents, they don't even have to wait the whole 5 months. They can then sell it all.

[learningcurve2020]

What I don’t understand is where are the higher quality EU financiers willing to finance mega bucks for a CDMO with an established facility? This should’ve happened already unless Advent truly has no business plan or clients other than NWBO and producing L.

[dstock07734]

See in the figure the replacement of BCG that Merck has the monopoly? What is the connection between the company that has the BCG replacement and Yorkville?

Don't look down on Yorkville. Its investment is long-term. It strikes me Yorkville is building an ecosystem with DCVAX as the center too. Just like what Merck, Amgen, Baker Brothers and others have been doing over the past five or ten years.

I don't worry about the approval at all. My only concern is how I can load more.

$NWBOhttps://t.co/6muteDK2u0
BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it has entered into… https://t.co/z9okR3yN7i

— d_stock (@d_stock07734) November 21, 2025

$NWBO

Better terms. And Yorkville can keep accumulating more shares.

Total Raised: $5,000,000
Net Proceeds: $4,750,000
Total Costs: $250,000
Costs as % of Total Raised: 5%

11-3-2025
CytoDyn Secures $30 Million Commitment from Yorkville Advisors https://t.co/jllHPCHjc3… https://t.co/2U2GorgchL

— d_stock (@d_stock07734) November 20, 2025